November 12, 2026 PDF Version MILLBRAE, Calif., Nov. 12, 2026 (GLOBE NEWSWIRE) — Eikon Therapeutics, Inc. (Nasdaq: EIKN) (Eikon), a late-stage clinical biopharmaceutical company dedicated to developing innovative medicines to…
Eikon Therapeutics Reports Third Quarter 2026 Financial Results and Provides Clinical Updates
calendar_today
November 12, 2026
domain
eikon